Cart
sales@molnova.com
ACA
CAS No. 110683-10-8
ACA( N-(p-amylcinnamoyl) Anthranilic Acid )
Catalog No. M20201 CAS No. 110683-10-8
N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 57 | In Stock |
|
| 100MG | 85 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameACA
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker.
-
DescriptionN-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker.
-
In Vitro——
-
In Vivo——
-
SynonymsN-(p-amylcinnamoyl) Anthranilic Acid
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorPLA2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number110683-10-8
-
Formula Weight337.42
-
Molecular FormulaC21H23NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (370.47 mM);Water:Insoluble
-
SMILESCCCCCc1ccc(\C=C\C(=O)Nc2ccccc2C(O)=O)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kraft R et al. Inhibition of TRPM2 cation channels by N-(p-amylcinnamoyl)anthranilic acid. Br J Pharmacol. 2006 Jun;148(3):264-73.
molnova catalog
related products
-
PACOCF3
PACOCF3 (Palmityltrifluoromethylketone) (Palmityltrifluoromet hylketone) is an inhibitor of Ca(2+)-independent phospholipase A2(PLA2) with an IC 50 of 3.8 μM.
-
9-Oxononanoic Acid
9-Oxononanoic Acid is an oxidized fatty acid, formed by the autoxidation of linoleic acid, which enhances phospholipase A2 (PLA2) activity and increases the production of thromboxane B2 in isolated human plasma.
-
Isepamicin sulfate
Isepamicin Sulphate, an aminoglycoside antibacterial with good activity against strains producing type I 6-acetyltransferase, inhibits bacterial protein synthesis by targeting the bacterial 30S ribosomal subunit.
